Grant Number:	1U54CA260582-01 Interpret this number
Primary Investigator:	Oltz, Eugene
Organization:	Ohio State University
Project Title:	Center for Serological Testing to Improve Outcomes From Pandemic COVID-19 (Stop-COVID)
Fiscal Year:	2020

Overall Project Summary Stemming the spread of COVID-19 will require research that cross-cuts basic, translational, and applied sciences. The Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP- COVID) is proposed as a transdisciplinary entity to understand the interface between exposure risk, transmission, immune responses, disease severity, protection, and barriers to testing/vaccination, with the goal of improving population health and clinical outcomes. The Center will utilize state-of-the-art serological and molecular tests, developed at OSU, in a longitudinal study of first responders, a group at continual high risk of SARS-CoV-2 exposure, as well as their household contacts. Through the proposed work, STOP-COVID investigators will understand critical aspects of: (i) transmission in both asymptomatic and symptomatic individuals, (ii) immune, host, and viral determinants of disease outcome, and (iii) factors associated with immune protection. Center investigators will also identify best practices for communication of test results and information about COVID-19 to improve understanding of risk, transmission, and protection, while reducing access barriers to testing. The Center to STOP-COVID will: Aim 1 Develop Institute Infrastructure through three shared resource cores: 1. An Administrative Core that provides overall direction and leadership, coordinating all Center activities as well as Project–Core–SeroNet interactions; 2. A Testing and Biorepository Core, whose role is to perform first-tier serologic and viral testing during our longitudinal study using high throughput ELISA and neutralization assays developed at OSU, and cost-shared by OSU; and 3. A Data Management and Analysis Core that will provide project investigators with a centralized resource for biostatistics, bioinformatics, epidemiology, and psychometrics expertise. Aim 2: Conduct three innovative research projects to address: Project 1: Parallel serological and viral testing to determine COVID-19 prevalence, transmission, and protection in extended first responder cohorts. This project will also generate serology data for vaccines or mAbs, once available to this presumably high-priority group; Project 2: Serologic and molecular determinants of COVID-19 severity and immune protection. This project will evaluate COVID-19 serological responses in the context of SARS-CoV-2 and common cold CoV (CCCoV) antibodies, using novel assays specific for a panel of antigens. Project 2 also will employ transcriptomics to understand how host genetics, CCCoV, other respiratory viruses, and immune responses contribute to pathogenesis; and Project 3: Responding to changing serological and viral information around COVID-19. This project will incorporate results from Projects 1 & 2 and SeroNet to inform best practices in risk communication, provide behavioral guidance to decrease transmission, and enhance protection from disease. Aim 3: SeroNet Participation and Sharing of Data and Best Practices. We will leverage STOP-COVID infrastructure to share data, results, reagents, and best practices with SeroNet, which will drive new discoveries and their translation into actionable strategies for implementation across all groups affected by COVID-19.




COVID-19 vaccination perspectives among patients with Long COVID: A qualitative study.
Authors: MacEwan S.R. , Rahurkar S. , Tarver W.L. , Gaughan A.A. , Rush L.J. , Schamess A. , McAlearney A.S. .
Source: Human Vaccines & Immunotherapeutics, 2024-12-31 00:00:00.0; 20(1), p. 2327663.
EPub date: 2024-03-26 00:00:00.0.
PMID: 38532547
Related Citations

The Impact of Long COVID on Employment and Well-Being: A Qualitative Study of Patient Perspectives.
Authors: MacEwan S.R. , Rahurkar S. , Tarver W.L. , Eiterman L.P. , Melnyk H. , Olvera R.G. , Eramo J.L. , Teuschler L. , Gaughan A.A. , Rush L.J. , et al. .
Source: Journal Of General Internal Medicine, 2024-10-08 00:00:00.0; , .
EPub date: 2024-10-08 00:00:00.0.
PMID: 39379779
Related Citations

Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants.
Authors: Li P. , Faraone J.N. , Hsu C.C. , Chamblee M. , Liu Y. , Zheng Y.M. , Xu Y. , Carlin C. , Horowitz J.C. , Mallampalli R.K. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2024-09-05 00:00:00.0; , .
EPub date: 2024-09-05 00:00:00.0.
PMID: 39282390
Related Citations

Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants.
Authors: Li P. , Faraone J.N. , Hsu C.C. , Chamblee M. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , Saif L.J. , et al. .
Source: Cell Reports, 2024-08-27 00:00:00.0; 43(8), p. 114520.
EPub date: 2024-07-17 00:00:00.0.
PMID: 39024099
Related Citations

Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.
Authors: Zhang Y. , Chamblee M. , Xu J. , Qu P. , Shamseldin M.M. , Yoo S.J. , Misny J. , Thongpan I. , Kc M. , Hall J.M. , et al. .
Source: Nature Communications, 2024-07-03 00:00:00.0; 15(1), p. 5589.
EPub date: 2024-07-03 00:00:00.0.
PMID: 38961063
Related Citations

Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion.
Authors: Li P. , Faraone J.N. , Hsu C.C. , Chamblee M. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , Saif L.J. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2024-05-21 00:00:00.0; , .
EPub date: 2024-05-21 00:00:00.0.
PMID: 38826376
Related Citations

Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.
Authors: Li P. , Liu Y. , Faraone J.N. , Hsu C.C. , Chamblee M. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , et al. .
Source: Mbio, 2024-05-08 00:00:00.0; 15(5), p. e0075124.
EPub date: 2024-04-09 00:00:00.0.
PMID: 38591890
Related Citations

Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion.
Authors: Li P. , Liu Y. , Faraone J. , Hsu C.C. , Chamblee M. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2024-03-11 00:00:00.0; , .
EPub date: 2024-03-11 00:00:00.0.
PMID: 38559216
Related Citations

Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
Authors: Faraone J.N. , Wang X. , Qu P. , Zheng Y.M. , Vincent E. , Xu H. , Liu S.L. .
Source: Journal Of Medical Virology, 2024 Mar; 96(3), p. e29520.
PMID: 38528837
Related Citations

Patient Experiences Navigating Care Coordination For Long COVID: A Qualitative Study.
Authors: MacEwan S.R. , Rahurkar S. , Tarver W.L. , Forward C. , Eramo J.L. , Teuschler L. , Gaughan A.A. , Rush L.J. , Stanwick S. , McConnell E. , et al. .
Source: Journal Of General Internal Medicine, 2024-02-02 00:00:00.0; , .
EPub date: 2024-02-02 00:00:00.0.
PMID: 38308155
Related Citations

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
Authors: Qu P. , Xu K. , Faraone J.N. , Goodarzi N. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , Saif L.J. , et al. .
Source: Cell, 2024-02-01 00:00:00.0; 187(3), p. 585-595.e6.
EPub date: 2024-01-08 00:00:00.0.
PMID: 38194968
Related Citations

mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer.
Authors: Song N.J. , Chakravarthy K.B. , Jeon H. , Bolyard C. , Reynolds K. , Weller K.P. , Reisinger S. , Wang Y. , Li A. , Jiang S. , et al. .
Source: Journal For Immunotherapy Of Cancer, 2024-01-04 00:00:00.0; 12(1), .
EPub date: 2024-01-04 00:00:00.0.
PMID: 38177076
Related Citations

Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19.
Authors: Adhikari B. , Bednash J.S. , Horowitz J.C. , Rubinstein M.P. , Vlasova A.N. .
Source: Frontiers In Immunology, 2024; 15, p. 1325243.
EPub date: 2024-02-07 00:00:00.0.
PMID: 38390335
Related Citations

Identifying beliefs driving COVID-19 vaccination: Lessons for effective messaging.
Authors: MacEwan S.R. , Kenah E. , Dixon G.N. , Stevens J. , Eiterman L.P. , Powell J.R. , Gage C.B. , Rush L.J. , Panchal A.R. , McAlearney A.S. .
Source: Human Vaccines & Immunotherapeutics, 2023-12-15 00:00:00.0; 19(3), p. 2266929.
EPub date: 2023-11-10 00:00:00.0.
PMID: 37947193
Related Citations

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3.
Authors: Faraone J.N. , Qu P. , Goodarzi N. , Zheng Y.M. , Carlin C. , Saif L.J. , Oltz E.M. , Xu K. , Jones D. , Gumina R.J. , et al. .
Source: Emerging Microbes & Infections, 2023 Dec; 12(2), p. 2270069.
EPub date: 2023-10-26 00:00:00.0.
PMID: 37819267
Related Citations

Continued evasion of neutralizing antibody response by Omicron XBB.1.16.
Authors: Faraone J.N. , Qu P. , Zheng Y.M. , Carlin C. , Jones D. , Panchal A.R. , Saif L.J. , Oltz E.M. , Gumina R.J. , Liu S.L. .
Source: Cell Reports, 2023-10-31 00:00:00.0; 42(10), p. 113193.
EPub date: 2023-09-30 00:00:00.0.
PMID: 37777967
Related Citations

The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review.
Authors: Gouchoe D.A. , Vijayakumar A. , Aly A.H. , Cui E.Y. , Essandoh M. , Gumina R.J. , Black S.M. , Whitson B.A. .
Source: Journal Of Thoracic Disease, 2023-10-31 00:00:00.0; 15(10), p. 5736-5749.
EPub date: 2023-09-11 00:00:00.0.
PMID: 37969313
Related Citations

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
Authors: Xu J. , Zhang Y. , Qu P. , Shamseldin M.M. , Yoo S.J. , Misny J. , Thongpan I. , Kc M. , Hall J.M. , Evans J.P. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2023-10-10 00:00:00.0; 120(41), p. e2220403120.
EPub date: 2023-10-05 00:00:00.0.
PMID: 37796985
Related Citations

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants.
Authors: Qu P. , Xu K. , Faraone J.N. , Goodarzi N. , Zheng Y.M. , Carlin C. , Bednash J.S. , Horowitz J.C. , Mallampalli R.K. , Saif L.J. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2023-09-12 00:00:00.0; , .
EPub date: 2023-09-12 00:00:00.0.
PMID: 37745517
Related Citations

Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID-19 pandemic.
Authors: Gaughan A.A. , MacEwan S.R. , Rush L.J. , Gatti-Mays M.E. , Pariser A.C. , McAlearney A.S. .
Source: Cancer Reports (hoboken, N.j.), 2023-08-16 00:00:00.0; , p. e1882.
EPub date: 2023-08-16 00:00:00.0.
PMID: 37584345
Related Citations

SARS-CoV-2 Serological Investigation of White-Tailed Deer in Northeastern Ohio.
Authors: Boley P.A. , Dennis P.M. , Faraone J.N. , Xu J. , Liu M. , Niu X. , Gibson S. , Hale V. , Wang Q. , Liu S.L. , et al. .
Source: Viruses, 2023-07-22 00:00:00.0; 15(7), .
EPub date: 2023-07-22 00:00:00.0.
PMID: 37515289
Related Citations

Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients.
Authors: MacEwan S.R. , Gaughan A.A. , Dixon G.N. , Olvera R.G. , Tarver W.L. , Rahurkar S. , Rush L.J. , Schenk A.D. , Stevens J. , McAlearney A.S. .
Source: Vaccines, 2023-06-22 00:00:00.0; 11(7), .
EPub date: 2023-06-22 00:00:00.0.
PMID: 37514950
Related Citations

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants.
Authors: Qu P. , Faraone J.N. , Evans J.P. , Zheng Y.M. , Carlin C. , Anghelina M. , Stevens P. , Fernandez S. , Jones D. , Panchal A.R. , et al. .
Source: Cell Reports, 2023-05-30 00:00:00.0; 42(5), p. 112443.
EPub date: 2023-04-18 00:00:00.0.
PMID: 37104089
Related Citations

Conflict in the EMS Workforce: An Analysis of an Open-Ended Survey Question Reveals a Complex Assemblage of Stress, Burnout, and Pandemic-Related Factors Influencing Well-Being.
Authors: Melnyk H. , Di Tosto G. , Powell J. , Panchal A.R. , McAlearney A.S. .
Source: International Journal Of Environmental Research And Public Health, 2023-05-18 00:00:00.0; 20(10), .
EPub date: 2023-05-18 00:00:00.0.
PMID: 37239587
Related Citations

Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants.
Authors: Faraone J.N. , Qu P. , Evans J.P. , Zheng Y.M. , Carlin C. , Anghelina M. , Stevens P. , Fernandez S. , Jones D. , Lozanski G. , et al. .
Source: Cell Reports. Medicine, 2023-05-16 00:00:00.0; 4(5), p. 101049.
EPub date: 2023-04-25 00:00:00.0.
PMID: 37148877
Related Citations

Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
Authors: Shamseldin M.M. , Kenney A. , Zani A. , Evans J.P. , Zeng C. , Read K.A. , Hall J.M. , Chaiwatpongsakorn S. , Mahesh K.C. , Lu M. , et al. .
Source: Journal Of Immunology (baltimore, Md. : 1950), 2023-05-01 00:00:00.0; 210(9), p. 1257-1271.
PMID: 36881867
Related Citations

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy.
Authors: Azar J.H. , Evans J.P. , Sikorski M.H. , Chakravarthy K.B. , McKenney S. , Carmody I. , Zeng C. , Teodorescu R. , Song N.J. , Hamon J.L. , et al. .
Source: Jci Insight, 2023-03-22 00:00:00.0; 8(6), .
EPub date: 2023-03-22 00:00:00.0.
PMID: 36749632
Related Citations

Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice.
Authors: Kenney A.D. , Zani A. , Kawahara J. , Eddy A.C. , Wang X.L. , Mahesh K.C. , Lu M. , Thomas J. , Kohlmeier J.E. , Suthar M.S. , et al. .
Source: Embo Reports, 2023-03-07 00:00:00.0; , p. e56660.
EPub date: 2023-03-07 00:00:00.0.
PMID: 36880581
Related Citations

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants.
Authors: Qu P. , Evans J.P. , Kurhade C. , Zeng C. , Zheng Y.M. , Xu K. , Shi P.Y. , Xie X. , Liu S.L. .
Source: Mbio, 2023-02-28 00:00:00.0; 14(1), p. e0317622.
EPub date: 2023-01-10 00:00:00.0.
PMID: 36625591
Related Citations

Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants.
Authors: Qu P. , Faraone J.N. , Evans J.P. , Zheng Y.M. , Carlin C. , Anghelina M. , Stevens P. , Fernandez S. , Jones D. , Panchal A. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2023-01-17 00:00:00.0; , .
EPub date: 2023-01-17 00:00:00.0.
PMID: 36711991
Related Citations

Perspectives of Volunteer Firefighters during the COVID-19 Pandemic: Stumbling Blocks and Silver Linings.
Authors: Gaughan A.A. , Rush L.J. , MacEwan S.R. , Panchal A.R. , McAlearney A.S. .
Source: Challenges, 2022 Dec; 13(2), .
EPub date: 2022-09-09 00:00:00.0.
PMID: 36213181
Related Citations

The COVID-19 vaccine concerns scale: Development and validation of a new measure.
Authors: Gregory M.E. , MacEwan S.R. , Powell J.R. , Volney J. , Kurth J.D. , Kenah E. , Panchal A.R. , McAlearney A.S. .
Source: Human Vaccines & Immunotherapeutics, 2022-11-30 00:00:00.0; 18(5), p. 2050105.
EPub date: 2022-04-05 00:00:00.0.
PMID: 35380510
Related Citations

Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
Authors: Qu P. , Evans J.P. , Faraone J.N. , Zheng Y.M. , Carlin C. , Anghelina M. , Stevens P. , Fernandez S. , Jones D. , Lozanski G. , et al. .
Source: Cell Host & Microbe, 2022-11-22 00:00:00.0; , .
EPub date: 2022-11-22 00:00:00.0.
PMID: 36476380
Related Citations

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2.
Authors: Qu P. , Evans J.P. , Faraone J. , Zheng Y.M. , Carlin C. , Anghelina M. , Stevens P. , Fernandez S. , Jones D. , Lozanski G. , et al. .
Source: Biorxiv : The Preprint Server For Biology, 2022-10-20 00:00:00.0; , .
EPub date: 2022-10-20 00:00:00.0.
PMID: 36299423
Related Citations

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant.
Authors: Qu P. , Evans J.P. , Zheng Y.M. , Carlin C. , Saif L.J. , Oltz E.M. , Xu K. , Gumina R.J. , Liu S.L. .
Source: Cell Host & Microbe, 2022-09-28 00:00:00.0; , .
EPub date: 2022-09-28 00:00:00.0.
PMID: 36240764
Related Citations

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
Authors: Qu P. , Faraone J.N. , Evans J.P. , Zheng Y.M. , Yu L. , Ma Q. , Carlin C. , Lozanski G. , Saif L.J. , Oltz E.M. , et al. .
Source: The New England Journal Of Medicine, 2022-09-07 00:00:00.0; , .
EPub date: 2022-09-07 00:00:00.0.
PMID: 36069925
Related Citations

The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.
Authors: Karger A.B. , Brien J.D. , Christen J.M. , Dhakal S. , Kemp T.J. , Klein S.L. , Pinto L.A. , Premkumar L. , Roback J.D. , Binder R.A. , et al. .
Source: Msphere, 2022-08-31 00:00:00.0; 7(4), p. e0019322.
EPub date: 2022-06-15 00:00:00.0.
PMID: 35703544
Related Citations

UV₂₂₂ disinfection of SARS-CoV-2 in solution.
Authors: Robinson R.T. , Mahfooz N. , Rosas-Mejia O. , Liu Y. , Hull N.M. .
Source: Scientific Reports, 2022-08-25 00:00:00.0; 12(1), p. 14545.
EPub date: 2022-08-25 00:00:00.0.
PMID: 36008435
Related Citations

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant.
Authors: Qu P. , Evans J.P. , Zheng Y.M. , Carlin C. , Saif L.J. , Oltz E.M. , Xu K. , Gumina R.J. , Liu S.L. .
Source: Biorxiv : The Preprint Server For Biology, 2022-08-15 00:00:00.0; , .
EPub date: 2022-08-15 00:00:00.0.
PMID: 36032970
Related Citations

SARS-CoV-2 and Emerging Foodborne Pathogens: Intriguing Commonalities and Obvious Differences.
Authors: Abdelhamid A.G. , Faraone J.N. , Evans J.P. , Liu S.L. , Yousef A.E. .
Source: Pathogens (basel, Switzerland), 2022-07-27 00:00:00.0; 11(8), .
EPub date: 2022-07-27 00:00:00.0.
PMID: 36014958
Related Citations

Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.
Authors: Cui Z. , Zeng C. , Huang F. , Yuan F. , Yan J. , Zhao Y. , Zhou Y. , Hankey W. , Jin V.X. , Huang J. , et al. .
Source: Nature Chemical Biology, 2022-07-25 00:00:00.0; , .
EPub date: 2022-07-25 00:00:00.0.
PMID: 35879545
Related Citations

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants.
Authors: Qu P. , Faraone J.N. , Evans J.P. , Zheng Y.M. , Carlin C. , Lozanski G. , Saif L.J. , Oltz E.M. , Gumina R.J. , Liu S.L. .
Source: Biorxiv : The Preprint Server For Biology, 2022-07-22 00:00:00.0; , .
EPub date: 2022-07-22 00:00:00.0.
PMID: 35898337
Related Citations

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination.
Authors: Tang J. , Zeng C. , Cox T.M. , Li C. , Son Y.M. , Cheon I.S. , Wu Y. , Behl S. , Taylor J.J. , Chakraborty R. , et al. .
Source: Science Immunology, 2022-07-19 00:00:00.0; , p. eadd4853.
EPub date: 2022-07-19 00:00:00.0.
PMID: 35857583
Related Citations

COVID-19 Booster Uptake among First Responders and Their Household Members May Be Lower than Anticipated.
Authors: Frey J.A. , Bachmann D.J. , Anghelina M. , Sircelj V. , Saadoon O. , Stevens P. , Pietrzak M. , Fernández S. , McAlearney A.S. , Panchal A.R. .
Source: Vaccines, 2022-06-24 00:00:00.0; 10(7), .
EPub date: 2022-06-24 00:00:00.0.
PMID: 35891175
Related Citations

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
Authors: Qu P. , Faraone J. , Evans J.P. , Zou X. , Zheng Y.M. , Carlin C. , Bednash J.S. , Lozanski G. , Mallampalli R.K. , Saif L.J. , et al. .
Source: The New England Journal Of Medicine, 2022-06-15 00:00:00.0; , .
EPub date: 2022-06-15 00:00:00.0.
PMID: 35704428
Related Citations

Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.
Authors: Eltobgy M.M. , Zani A. , Kenney A.D. , Estfanous S. , Kim E. , Badr A. , Carafice C. , Daily K. , Whitham O. , Pietrzak M. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2022-05-24 00:00:00.0; 119(21), p. e2202012119.
EPub date: 2022-05-19 00:00:00.0.
PMID: 35588457
Related Citations

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
Authors: Evans J.P. , Qu P. , Zeng C. , Zheng Y.M. , Carlin C. , Bednash J.S. , Lozanski G. , Mallampalli R.K. , Saif L.J. , Oltz E.M. , et al. .
Source: The New England Journal Of Medicine, 2022-05-18 00:00:00.0; , .
EPub date: 2022-05-18 00:00:00.0.
PMID: 35584183
Related Citations

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.
Authors: Evans J.P. , Zeng C. , Qu P. , Faraone J. , Zheng Y.M. , Carlin C. , Bednash J.S. , Zhou T. , Lozanski G. , Mallampalli R. , et al. .
Source: Cell Host & Microbe, 2022-04-25 00:00:00.0; , .
EPub date: 2022-04-25 00:00:00.0.
PMID: 35526534
Related Citations

Pandemic Experience of First Responders: Fear, Frustration, and Stress.
Authors: McAlearney A.S. , Gaughan A.A. , MacEwan S.R. , Gregory M.E. , Rush L.J. , Volney J. , Panchal A.R. .
Source: International Journal Of Environmental Research And Public Health, 2022-04-13 00:00:00.0; 19(8), .
EPub date: 2022-04-13 00:00:00.0.
PMID: 35457559
Related Citations

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection.
Authors: Evans J.P. , Zeng C. , Carlin C. , Lozanski G. , Saif L.J. , Oltz E.M. , Gumina R.J. , Liu S.L. .
Source: Science Translational Medicine, 2022-03-23 00:00:00.0; 14(637), p. eabn8057.
EPub date: 2022-03-23 00:00:00.0.
PMID: 35166573
Related Citations